Amydis Announces Successful Completion of a Pre-IND Meeting with the FDA for the Development of a First-in-Class Retinal Tracer Targeting TDP43 for the Diagnosis of ALS
December 06, 2021 07:00 ET
|
Amydis, Inc.
SAN DIEGO, Dec. 06, 2021 (GLOBE NEWSWIRE) -- Amydis Inc., a biotechnology company developing novel ocular contrast agents (“tracers”) targeting CNS biomarkers in the eye, today announced the...
EDRN's Pancreatic Cancer Detection Group Teams With Rhino Health to Leverage Federated Learning and Accelerate Medical Research
November 23, 2021 09:00 ET
|
Rhino HealthTech, Inc.
BOSTON, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Rhino Health today announced a pilot project with the pancreatic cancer working group of the National Cancer Institute's Early Detection Research Network...
HealthTab™ Expands to British Columbia in Select Shoppers Drug Mart® Locations
October 26, 2021 08:00 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, Oct. 26, 2021 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) announces that it has expanded patient testing with the HealthTab™ platform...
Amydis Awarded $3 Million NIH Grant to Explore Novel Alpha Synuclein Retinal Tracer in Non-human Primate Models of Parkinson’s Disease and Multiple System Atrophy
October 11, 2021 07:00 ET
|
Amydis, Inc.
SAN DIEGO, Oct. 11, 2021 (GLOBE NEWSWIRE) -- Amydis Inc., a leading ocular tracer pharmaceutical company with a broad portfolio of diagnostic drug candidates targeting CNS biomarkers in the eye,...
Amydis Receives NIH Grant Award to Develop a Novel Tau Retinal Tracer for Alzheimer's Diseases and other Tauopathies
September 02, 2021 07:00 ET
|
Amydis, Inc.
SAN DIEGO, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Amydis Inc., a leading ocular tracer pharmaceutical company with a broad portfolio of diagnostic drug candidates targeting CNS biomarkers in the eye,...
HealthTab™ Systems Deployed in Select Shoppers Drug Mart® Locations, Patient Testing Begins
August 10, 2021 05:00 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, Aug. 10, 2021 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) announces that patient testing has begun on the HealthTab™ platform in...
Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
July 28, 2021 09:55 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, July 28, 2021 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce it has signed a partnership...
HealthTab™ Adds ID Now™ Molecular Test Device to Abbott Distribution Agreement, Now Offers First Real-time Reporting of SARS-CoV-2, Flu, Strep and RSV System in Pharmacy
July 26, 2021 08:00 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, July 26, 2021 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce the signing of the first...
Beta-Testing of New HealthTab™ System in First Shoppers Drug Mart® Pharmacy Performs Well, Shows Strong Patient Demand
July 19, 2021 09:33 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, July 19, 2021 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) announces that patient testing has begun on the first deployment of the new...
Avricore Health CEO Hosts Investor Call July 6th
June 30, 2021 07:00 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, June 30, 2021 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) is hosting the first of a regular series of investor calls hosted by the...